Powered by the US FDA Cleared AI solution CXR Analyzer, Augmento X-Ray covers the entire chest area
DeepTek.ai has announced the commercial availability of Augmento X-Ray, a CADe Chest X-Ray AI solution powered by US FDA Cleared CXR AI at the Radiology Society of North America’s (RSNA) 109th Annual Meeting. Augmento X-Ray is designed to significantly reduce radiologist workload and improve the quality of chest X-ray reporting.
By seamlessly differentiating chest radiographs without suspicion from those with suspicions, Augmento X-Ray helps reduce the backlog of chest X-rays, improving the radiology workflow and enhancing overall patient care.
Powered by the US FDA Cleared AI solution CXR Analyzer, Augmento X-Ray covers the entire chest area, providing in-depth analysis for a wide spectrum of lung, pleura, cardiac findings, as well as detection of foreign bodies and hardware within the chest.
Ajit Patil, Co-Founder, DeepTek said, “Augmento X-Ray represents a significant breakthrough in AI-powered medical imaging. With the US FDA clearance, Augmento X-Ray is now available in the US market, and we look forward to expanding our reach in this important market, helping healthcare providers deliver better care to their patients.”